Lv5
830 积分 2021-11-30 加入
Neoadjuvant Non-Ablative SBRT Plus Immunotherapy Yields Similar Pathologic Response as Chemo-Immunotherapy in Non-Small Cell Lung Cancer
1天前
求助中
Dissecting the clinicopathological, genomic, and prognostic significance of ALK rearrangement in resected lung adenocarcinoma
14天前
已完结
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
1个月前
已完结
Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial
1个月前
已完结
Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial
3个月前
已完结
Extracellular matrix stiffness and Wnt/β-catenin signaling in physiology and disease
5个月前
已完结
Determinants of successful minimally invasive surgery (MIS) for resectable non-small cell lung cancer (NSCLC) after neoadjuvant therapy
7个月前
已完结
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer
8个月前
已完结
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC
8个月前
已完结
The Role of Salvage Resection After Definitive Radiation Therapy for Non-small Cell Lung Cancer
8个月前
已完结
皖公网安备34019202002308
